Welcome to the “news” section of our website, where you'll find all the latest publications on our advances in research (Alzheimer's, Parkinson's, Charcot's disease, etc.), our upcoming events, etc.
Paris, December 11, 2024. Identifying and supporting innovative neuroscience projects up to the creation of viable startups: this is the mission of iPEPS, Paris Brain Institute's startup studio. Through the NeurAL program, launched in 2023 and...
With support from the Anne and Claude Berda Foundation and from Indosuez Wealth Management, Paris Brain Institute is launching the second edition of NeurAL, its startup studio program.
Paris Brain Institute is pleased to announce its membership to EBRAINS AISBL, a new digital research infrastructure (RI), created by the EU-funded Human Brain Project (HBP), to foster brain-related research.
Forbes France magazine unveiled in its latest issue the ranking of its fifth edition "30 Under 30". This ranking is dedicated to a new generation of entrepreneurs who disrupt the codes of their field: sports, finance, art, entertainment, environment...
On November 18, Station F unveiled the second edition of its Future 40 ranking. 2 startups hosted in our incubator iPEPS -The Healthtech Hub are included: Healthy Mind and Uptale.
The World Economic Forum is held from January 23 to 26. Some 70 heads of state and government are expected to participate in this popular meeting of bosses from around the world.
MedDay, a biotechnology company centred on disorders of the nervous system and incubated at the Brain and Spine Institute – Institut du Cerveau - ICM, announced today that the main criterion of its pivotal clinical trial MS-SPI was attained. The...
MedDay is a French biotech company in the treatment of neuro-metabolic diseases. Founded in 2011 by Frédéric Sedel and Guillaume Brion, MedDay relies on the work of Dr Frédéric Sedel, a neuroscientist at La Pitié Salpêtrière Hospital (Paris), who has...
